Page 2 - Best Small intestine cancer doctors in Istanbul: TOP 30 doctors

Assoc. Prof. Dr. Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over a decade of experience in oncology
• Former physician at Ankara Oncology Clinic
• Associate Professor since 2016
• Trained at Selcuk University Faculty of Medicine

Dr. Muzaffer Al specializes in laparoscopic surgery for small intestine cancer, with advanced training from Istanbul University's top medical programs.

• Board-certified surgeon with over 20 years of experience
• Expert in laparoscopic antireflux and bariatric surgery
• Trained in oncological cancer surgery at Cerrahpaşa Faculty of Medicine

Dr. Kinas specializes in complex gastrointestinal cancers, including small intestine cancer, at Büyük Anadolu Hospitals.

• Expertise in pancreatic and bile duct surgeries
• Performs oncological surgeries for various gastrointestinal cancers
• Skilled in advanced bariatric and metabolic procedures

Professor in Radiation Oncology with 20+ years specializing in cancer treatment – now at Istanbul Medipol University.

• Trained at Istanbul University and Kadir Has University
• Associate Professor then full Professor at Demiroglu Bilim University
• Works in radiation oncology departments at leading Istanbul hospitals
• Handles complex cases requiring precision radiation therapy

Professor of Medical Oncology with over 20 years of experience – Dr. Saglam specializes in gastrointestinal oncology at Istanbul Florence Nightingale Hospital.

• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO, ASCO, and ENET – leading oncology societies
• Attending physician in Gastrointestinal Oncology since 2005

Assoc. Prof. Gorkem Turkkan has successfully completed over 2,500 radiotherapy sessions with the MR-Linac device, specializing in advanced treatments for small intestine cancer.

• Radiation oncology specialist with expertise in stereotactic and MRI-guided radiotherapy
• Member of the European Society of Radiotherapy and Oncology (ESTRO) since 2015
• Associate Professor with extensive academic and clinical research experience
• Published 27 articles in domestic and international journals

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.